<DOC>
	<DOC>NCT01239069</DOC>
	<brief_summary>Investigate the Safety and Efficacy of Two Concentrations of DE-110 Compared to Placebo for the Treatment of Dry Eye Disease</brief_summary>
	<brief_title>Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Confirmed diagnosis of dry eye Not wear contact lenses during study 18 years or older Understand and provide written consent Negative pregnancy test and use acceptable method of contraception Use of any topical ocular medication Any type of ocular surgery Diagnosis of ongoing ocular infection and/or allergic conjunctivitis Uncontrolled systemic conditions/lid abnormalities Corneal transplants Females who are pregnant, nursing or planning a pregnancy Participation in another drug trial concurrently or within 30 days prior to study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>